Anti-BCMA CAR T Cells

Overview

Anti-BCMA CAR T Cells are a BCMA targeted CAR T Cell therapy being developed at the National Cancer Institute.

SparkCures ID	127
Generic Name	Anti-BCMA CAR T Cells
Treatment Classifications	Adoptive Cellular Therapy CAR T Cell T Cell Engager (TCE)
Treatment Targets	B-Cell Maturation Antigen (BCMA)

No active clinical trials

There are no resources, links or videos to display for this treatment.